|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 20710059.5 (espacenet) (Federated) (European Patent Register), 20200224 | | Patent/reg. no. and date | DK/EP 3927337, 20240214 | | Publication date | 20211229 | | Priority no. and date | EP 19158774, 20190222 | | EP pub. no. and date |
EP 3927337 20211229 | | Effective date | | | Applicant/owner | GH Research Ireland Limited, Joshua Dawson House Dawson Street
D02 RY95 Dublin 2, IE | | Applicant ref. no. | V475063DK00 | | Inventor | Terwey, Theis, Christinenstrasse 33
10119 Berlin, DE | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4045 (2006.01) , A61P 25/24 (2006.01) | | Title | 5-Methoxy-N,N-dimethyltryptamin (5-MeO-DMT) til behandling af svær depression | | Int. application no. | EP2020054803 | | Int. publication no. | WO2020169850 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
